ABCB1 upregulation may have played a role in taxol resistance at some point in the tumor’s evolutionary trajectory, but then additional drug resistance mechanisms became more dominant, such that inhibiting MDR1 in OCM is not sufficient to re-sensitize. Here, ABCB1 is linked to neoplasm.